Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: A randomized trial

JAMA

Volumn 287, Issue 1, 2002, Pages 64-71

  Geba, Gregory P ^a   Weaver, Arthur L ^b   Polis, Adam B ^a   Dixon, Mary E ^a   Schnitzer, Thomas J ^c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Arthritis Center Nebraska   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; ROFECOXIB;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED STATES;

EID: 0037006122     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.1.64     Document Type: Article

References (30)

1. The management of osteoarthritis in older adults
2. The economics of osteoarthritis
3. The course of osteoarthritis and factors that affect it
4. Guidelines for the medical management of osteoarthritis, II: Osteoarthritis of the knee
5. Recommendations for the medical management of osteoarthritis of the hip and knee
6. Preference for non-steroidal anti-inflammatory drugs vs acetaminophen and concomitant use of both types of drugs in osteoarthritis
7. Preference for nonsteroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: A survey of 1799 patients with osteoarthritis, rheumatoid arthritis and fibromyalgia
8. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide
9. Interleukin-1 differentially modulates chondrocyte expression of cyclooxygenase-2 and phospholipase A2
10. Induction of cydooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo
11. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues
12. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other nonsteroidal anti-inflammatory drugs
13. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
14. Gastointestinal toxicity caused by non-steroidal anti-inflammatory drugs (NSAIDs) is the most frequent drug side effect in the United States
15. Efficacy of specific Cox-2 inhibition in osteoarthritis of the knee: A 6 week double-blind, placebo controlled, pilot study of rofecoxib
16. A randomized trial of the efficacy and tolerability of the Cox-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis
17. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial
18. Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee
19. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
20. A double-blind comparison of rofecoxib and naproxen on the incidence of clinically important upper gastrointestinal events: The VIGOR trial
21. Gastrointestinal toxicity with celecoxib vs non-steroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized, controlled trial
22. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee
23. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis
24. Validation study of WOMAC
25. Design and conduct of clinical trials with osteoarthritis: Recommendation from a task force of the Osteoarthritis Research Society: Results from a workshop
26. Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee
27. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee
28. A randomized, double-blind, cross-over clinical trial of diclofenac plus misoprostol vs acetaminophen in patients with osteoarthritis of the hip or knee
29. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis